F81-1144b
F81-1144b is a MMP-1 and MMP-3 inhibitor with IC50 values of 5 nM and 29 nM, respectively. F81-1144b reduces serum and hepatic triacylglycerol levels, decreases the secretion of very-low-density lipoprotein-triacylglycerol, inhibits de novo hepatic fatty acid synthesis, and lowers serum insulin and glucose levels. F81-1144b can be used for the research of hypertriglyceridemia.
For research use only. We do not sell to patients.
- CAS No.: 306733-22-2
- Formula: C27H37N3O5
- Molecular Weight:483.60
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
MMP-1 5 nM (IC50) |
MMP-3 27 nM (IC50) |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar rats (7-week-old male; high-sucrose diet-induced hypertriglyceridemia)[1]
-
Dosage:50 mg/kg; 100 mg/kg
-
Administration:s.c.; once daily; 7 days
-
Result:Reduced serum TAG levels in a dose-dependent manner, with 100 mg/kg restoring levels to normal diet-fed control values.
Reduced serum cholesterol levels in a dose-dependent manner, with 100 mg/kg restoring levels to normal diet-fed control values.
Returned slightly elevated serum glucose levels to normal values at both 50 mg/kg and 100 mg/kg.
Markedly reduced HSD-elevated serum insulin levels.
Significantly reduced hepatic TAG levels in a dose-dependent manner; did not significantly change hepatic phospholipid levels.
Significantly suppressed hepatic de novo fatty acid synthesis at 100 mg/kg.
Significantly decreased HSD-elevated microsomal glycerol-3-phosphate acyltransferase (GPAT) activity at 100 mg/kg.
Upregulated hepatic gene expression of Lpl, Cd36, Apoa1, Ucp2 in a dose-dependent manner.
Chemical Information
-
CAS No. 306733-22-2
-
Molecular Weight 483.60
-
Formula C27H37N3O5
-
SMILES
O=C([C@H](CC1=CC=C(C=C1)CN)NC([C@@H]([C@H](CCCC2=CC=CC=C2)C(NO)=O)CC(C)C)=O)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)